Novo Nordisk Says CagriSema Produced 25% Average Weight Loss in Women
Novo Nordisk said its experimental CagriSema showed average weight loss of 25% among women with obesity or overweight, based on analysis after completion of a late-stage study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.